QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Targacept, Inc. (TRGT) Says AstraZeneca will Advance Alzheimer’s Drug 0 comments
    Jan 5, 2012 2:24 PM | about stocks: CBIO
    Targacept, Inc. currently has five mid-to-late-stage drug candidates using innovative NNR Therapeutics for difficult to treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulates the activity of specific neuronal nicotinic receptors, which are unique proteins that regulate vital biological functions.

    The company today reported AstraZeneca has informed Targacept that it plans to progress the development of Targacept’s product candidate AZD1446 as a treatment for Alzheimer’s disease. AZD1446 is a selective modulator of the alpha4beta2 neuronal nicotinic receptor that arose out of a research collaboration between the two companies.

    The two companies signed a collaborative research and license agreement in 2005. Under terms of this agreement, AstraZeneca is responsible for conducting and funding the development and potential commercialization of AZD1446.

    The next clinical trial of AZD1446 is expected to be a Phase 2 study as an adjunct treatment to donepezil in patients with mild to moderate Alzheimer’s disease. This study will complement the ongoing Phase 2b study of another of Targacept’s drugs, AZD3480, being used as a sole therapy for treatment of Alzheimer’s disease.

    For further information about Targacept and its pipeline of drugs, please visit the company’s website at targacept.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net
    Stocks: CBIO
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.